Project Grant R21AI185572
Award Date
5/5/25
Completion Date
4/30/27
Dollars Obligated
$213K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $924,000 in funding to Tufts University School of Medicine. The award aims to support research focused on mitigating the adhesion of Plasmodium falciparum-infected red blood cells to endothelial cells, a key factor in the development of severe and often fatal cerebral malaria. The research project will...
This $676,425 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the mechanisms by which the Plasmodium falciparum parasite causes neutrophil dysfunction during malaria infection. The research team at The Washington University aims to identify how the parasite's secreted histidine-rich protein II (HRPII) impairs the oxidative burst activity of neutrophils, a...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $520,809 to Rosalind Franklin University of Medicine & Science to conduct research on the role of TAM receptors in modulating the humoral immune response against parasitic infections, particularly malaria. The research aims to investigate how malaria-induced hemolytic anemia and resulting systemic hypoxia can...
This $707,696 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to identify volatile organic compounds in human scent signatures that modulate attractiveness to the African malaria mosquito Anopheles gambiae, a primary vector for malaria transmission in sub-Saharan Africa. The research aims to characterize the contribution of the human skin microbiome to these scent signatures...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to examine the impact of immune inhibitory receptor signaling on monocyte and T cell functions during subclinical malaria infections in children. The $184,109 award, running from December 2024 to November 2026, will enable researchers at the Cleveland Clinic Lerner College of Medicine of Case Western...
This federal Project Grant award for $400,347.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to profile malarial lipid biosynthesis and characterize the roles of two key acyl-coenzyme A synthetase enzymes, ACS10 and ACS11, in Plasmodium falciparum fatty acid uptake and metabolism. The research project, conducted by Virginia Polytechnic Institute & State...
The University of Georgia Research Foundation was awarded a $540,193 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The 12-month award, effective August 22, 2023, supports research to investigate the role of calcium-binding proteins and other secretory pathway components in the exocytosis of organelles critical for the invasion and egress of the malaria parasite Plasmodium falciparum...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $479,204 Project Grant (CFDA 93.855) to the University of Maryland, Baltimore to conduct research on parasite variant surface antigens and their role in severe malaria. The 2-year project, titled "Parasite Variant Surface Antigen Expression and Immune Gaps in Severe Malaria," aims to identify parasite genes associated with severe malaria in order to inform the development of vaccines or therapeutics. The...
This $215,860 federal Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant aims to continue a successful clinical and translational research portfolio focused on improving the diagnosis, treatment, and prevention of HIV-related central nervous system (CNS) infections, such as cryptococcal and tuberculosis meningitis. Key research objectives include: Enrolling a...
This federal Project Grant award of $699,814 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand the molecular mechanisms of malaria parasite-mosquito midgut interactions and develop new transmission-blocking approaches. The key objectives are to functionally characterize mosquito and parasite proteins that mediate these interactions, evaluate their potential as...